For the inv plans, a significant dose reduction has
been achieved for 87% of the OARs, while maintaining the target coverage. In
the forward plans, the median Dmax
OAR was 14.9 Gy (men) and 14.1 Gy (vs) and was reduced to 12.25 Gy (men,
p=0.002) and 12.95 Gy (vs, p=0.007) in the inv plans. For the fc plans, a reduction was observed in 53% of
the OARs where the median Dmax
OAR was lowered to 14.4 Gy (men, p=0.192) and 13.35 Gy (vs, p=0.985).
Additionally, the fc plans resulted in significantly higher target coverage.
The median coverage rose from 0.98 (men) and 0.97 (vs) to 1.0 (men, p=0.005)
and 0.99 (vs, p=0.006).
The BOT was significantly shortened for 87% of the inv
and fc plans. The median BOT was reduced for men from 22.5 min to 18.5 min
(inv, p=0.007) and 19 min (fc, p=0.017) and for vs from 19.3 min to 15 min
(inv, p=0.008) and 9.8 min (fc, p=0.01).